Oracle, Dell Dip in Thursday's Market Cap Stock Movers
Thursday's trading session is witnessing notable fluctuations among stocks across the board, with significant movements in both the mega-cap and large-cap categories.
Oracle Corp
(NYSE:
ORCL
) and
Dell Inc
(NYSE:
DELL
) are among the stocks experiencing declines, while
MicroStrategy Inc
(NASDAQ:
MSTR
) is surging. Here's a look at some of the key stock movers today, spanning from mega-caps to small caps.
Mega-Cap Movers (Market Cap $200B+):
-
Oracle Corp (ORCL): -4.03%
-
Salesforce Com
(NYSE:
CRM
): -3.84%
-
Avago Technologies
(NASDAQ:
AVGO
): -3.08%
-
Servicenow Inc
(NYSE:
NOW
): -2.68%
-
Adobe Sys Inc
(NASDAQ:
ADBE
): -2.21%
Large-Cap Stock Movers (Market Cap $10B-$200B):
-
Dell Inc (DELL): -12.25%
-
Hewlett-pack
(NYSE:
HPQ
): HP stock downgraded to Hold by HSBC on weak 1QFY25 outlook and rising commodity costs; -11.36%
-
MicroStrategy Inc (MSTR): +9.94%
-
Autodesk Inc
(NASDAQ:
ADSK
): -8.59%
-
Nutanix Inc
(NASDAQ:
NTNX
): Nutanix to Present at Upcoming Investor Conference; -7.81%
-
BeiGene
(NASDAQ:
BGNE
): +7.31%
-
Reinvent Technology Partners Y (AUR): +7.27%
-
Li Auto Inc
(NASDAQ:
LI
): American Lithium Reports Results of Annual General and Special Meeting; +6.78%
-
IBIT NASDAQ (IBIT): +6.44%
-
FBTC NYSE (FBTC): +6.37%
Mid-Cap Stock Movers (Market Cap $2B-$10B):
-
SVF Investment 3 (SYM): -35.87%
-
Iris Energy (IREN): +29.71%
-
Arrowhead Research Corp
(NASDAQ:
ARWR
): +24.23%
-
Urban outfitters
(NASDAQ:
URBN
): +18.31%
-
Hut 8
Mining
PK (HUT): +16.5%
-
HCM Acquisition (MRNO): +16.17%
-
Good Works Acquisition (CIFR): +14.56%
-
MSTU (MSTU): +13.93%
Small-Cap Stock Movers (Market Cap $300M-$2B):
-
Advanced Photonix Inc (API): +33.97%
-
ETHU (ETHU): +18.79%
-
Golden Bull (BTBT): +18.45%
-
Fate Therap
(NASDAQ:
FATE
): +18.28%
-
Kingsoft Cloud Holdings Ltd (KC): +17.42%
-
Immunome Inc
(NASDAQ:
IMNM
): +16.83%
-
Wowo Ltd (MFH): -16.32%
-
Semler Scientifc
(NASDAQ:
SMLR
): +16.06%
-
Applied Therapeutics Inc
(NASDAQ:
APLT
): FDA declines approval for Applied Therapeutics' Galactosemia drug; -16.06%
For real-time, market-moving news, join Investing Pro.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.